Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0265264 (
HOS
)
1,119
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The T-box gene tbx5 is expressed in the developing heart, forelimb, eye, and liver in vertebrate embryos during critical stages of morphogenesis and patterning. In humans, mutations in the
TBX5
gene have been associated with
Holt-Oram syndrome
, which is characterized by developmental anomalies in the heart and forelimbs. In chicken and mouse embryos, tbx5 expression is initiated at the earliest stages of heart formation throughout the heart primordia and is colocalized with other cardiac transcription factors such as nkx-2.5 and GATA4. As the heart differentiates, tbx5 expression is restricted to the posterior sinoatrial segments of the heart, consistent with the timing of atrial chamber determination. The correlation between tbx5 expression and atrial lineage determination was examined in retinoic acid (RA)-treated chicken embryos. tbx5 expression is maintained throughout the hearts of RA-treated embryos under conditions that also expand atrial-specific gene expression. The downstream effects of persistent tbx5 expression in the ventricles were examined directly in transgenic mice. Embryos that express tbx5 driven by a beta-myosin heavy chain promoter throughout the primitive heart tube were generated. Loss of ventricular-specific gene expression and retardation of ventricular chamber morphogenesis were observed in these embryos. These studies provide direct evidence for an essential role for tbx5 in early heart morphogenesis and chamber-specific gene expression.
...
PMID:Ventricular expression of tbx5 inhibits normal heart chamber development. 1086 69
Mutations in the
TBX5
transcription factor gene cause human cardiac malformation in
Holt-Oram syndrome
. To identify and localize
TBX5
during cardiac morphogenesis, we performed immunohistochemical studies of
TBX5
protein cardiac expression during human embryogenesis. Specific antibody to human
TBX5
was generated in rabbits with a
TBX5
synthetic peptide and affinity purification of antiserum. Anti-
TBX5
was used in immunohistochemical analyses of human cardiac tissue. In embryonic and adult heart,
TBX5
is expressed throughout the epicardium and in cardiomyocyte nuclei in myocardium of all four cardiac chambers. Endocardial expression of
TBX5
is only present in left ventricle. Asymmetric left-sided transmyocardial gradients of
TBX5
protein expression were observed in embryonic but not adult hearts. Human cardiac expression of
TBX5
protein correlates with the cardiac manifestations of
Holt-Oram syndrome
.
TBX5
transmyocardial protein gradients may contribute to normal patterning of the human heart during embryogenesis.
...
PMID:Identification and localization of TBX5 transcription factor during human cardiac morphogenesis. 1097 75
Mutations in human
TBX5
, a member of the T-box transcription factor gene family, cause congenital cardiac septation defects and isomerism in autosomal dominant
Holt-Oram syndrome
. To determine the cellular function of
TBX5
in cardiogenesis, we overexpressed wild-type and mutant human
TBX5
isoforms in vitro and in vivo.
TBX5
inhibited cell proliferation of D17 canine osteosarcoma cells and MEQC quail cardiomyocyte-like cells in vitro. Mutagenesis of the 5' end of the T-box but not the 3' end of the T-box abolished this effect. Overexpression of
TBX5
in embryonic chick hearts showed that
TBX5
inhibits myocardial growth and trabeculation.
TBX5
effects in vivo were abolished by Gly80Arg missense mutation of the 5' end of the T-box. PCNA analysis in transgenic chick hearts revealed that
TBX5
overexpression does suppress embryonic cardiomyocyte proliferation in vivo. Inhibitory effects of
TBX5
on cardiomyocyte proliferation include a noncell autonomous process in vitro and in vivo.
TBX5
inhibited proliferation of both nontransgenic cells cocultured with transgenic cells in vitro and nontransgenic cardiomyocytes in transgenic chick hearts with mosaic expression of
TBX5
in vivo. Immunohistochemical studies of human embryonic tissues, including hearts, also demonstrated that
TBX5
expression is inversely related to cellular proliferation. We propose that
TBX5
can act as a cellular arrest signal during vertebrate cardiogenesis and thereby participate in modulation of cardiac growth and development.
...
PMID:TBX5 transcription factor regulates cell proliferation during cardiogenesis. 1116 71
Septation defects and patent ductus arteriosus are the most common human cardiovascular malformations (CVMs). Genetic factors play a major part in the origin of these malformations. Recent molecular analyses have shed light on several mendelian forms. In the autosomal dominant
Holt-Oram syndrome
, both atrial and ventricular septal defects are inherited in association with limb deformity as a result of mutations in the gene encoding the
TBX5
transcription factor. Mutations in the NKX2.5 transcription factor gene cause autosomal dominant familial atrial septal defects in association with progressive atrioventricular block as well as complex congenital heart disease. Common atrial syndromes in autosomal dominant Ellis-van Creveld syndrome arise in the context of axial skeletal and limb malformation as a result of mutations in the EVC gene, whose function is unknown. Patent ductus arteriosus occurs in several syndromic forms of congenital heart disease, including
Holt-Oram syndrome
. Recent analyses of autosomal dominant Char syndrome, which includes, with variable penetrance, patent ductus arteriosus as well as craniofacial and hand malformations, have shown that the syndrome is caused by mutations in the TFAP2B transcription factor gene. Ongoing analyses are poised to determine the contribution of these genes as well as others yet to be identified to common, sporadic forms of congenital heart disease.
...
PMID:Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. 1137 42
The cardiac homeobox protein Nkx2-5 is essential in cardiac development, and mutations in Csx (which encodes Nkx2-5) cause various congenital heart diseases. Using the yeast two-hybrid system with Nkx2-5 as the 'bait', we isolated the T-box-containing transcription factor Tbx5; mutations in
TBX5
cause heart and limb malformations in
Holt-Oram syndrome
(
HOS
). Co-transfection of Nkx2-5 and Tbx5 into COS-7 cells showed that they also associate with each other in mammalian cells. Glutathione S-transferase (GST) 'pull-down' assays indicated that the N-terminal domain and N-terminal part of the T-box of Tbx5 and the homeodomain of Nkx2-5 were necessary for their interaction. Tbx5 and Nkx2-5 directly bound to the promoter of the gene for cardiac-specific natriuretic peptide precursor type A (Nppa) in tandem, and both transcription factors showed synergistic activation. Deletion analysis showed that both the N-terminal domain and T-box of Tbx5 were important for this transactivation. A G80R mutation of Tbx5, which causes substantial cardiac defects with minor skeletal abnormalities in
HOS
, did not activate Nppa or show synergistic activation, whereas R237Q, which causes upper-limb malformations without cardiac abnormalities, activated the Nppa promoter to a similar extent to that of wildtype Tbx5. P19CL6 cell lines overexpressing wildtype Tbx5 started to beat earlier and expressed cardiac-specific genes more abundantly than did parental P19CL6 cells, whereas cell lines expressing the G80R mutant did not differentiate into beating cardiomyocytes. These results indicate that two different types of cardiac transcription factors synergistically induce cardiac development.
...
PMID:Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. 1143
Holt-Oram syndrome
is caused by mutations in
TBX5
, a member of the T-box gene family. In order to identify DNA sequences to which the
TBX5
protein binds, we have performed an in vitro binding site selection assay. We have identified an 8 bp core sequence that is part of the Brachyury consensus-binding site. We show that
TBX5
binds to the full palindromic Brachyury binding site and to the half-palindrome, whereas Brachyury does not bind to the
TBX5
site. Amino acids 1-237 of
TBX5
are required for DNA binding. Analysis of the effects of specific substitution mutations that arise in
Holt-Oram
patients indicates that G80R and R237Q eliminate binding to the target site. DNA database analysis reveals that target sites are present in the upstream regions of several cardiac-expressed genes including cardiac alpha actin, atrial natriuretic factor, cardiac myosin heavy chain alpha, cardiac myosin heavy chain beta, myosin light chain 1A, myosin light chain 1V and Nkx2.5. Cell transfection studies demonstrate that
TBX5
activates the transcription of an atrial natriuretic factor reporter construct and this effect is significantly reduced by deletion of the
TBX5
binding site.
...
PMID:Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. 1155 35
Heterozygous Tbx5(del/+) mice were generated to study the mechanisms by which
TBX5
haploinsufficiency causes cardiac and forelimb abnormalities seen in
Holt-Oram syndrome
. Tbx5 deficiency in homozygous mice (Tbx5(del/del)) decreased expression of multiple genes and caused severe hypoplasia of posterior domains in the developing heart. Surprisingly, Tbx5 haploinsufficiency also markedly decreased atrial natriuretic factor (ANF) and connexin 40 (cx40) transcription, implicating these as Tbx5 target genes and providing a mechanism by which 50% reduction of T-box transcription factors cause disease. Direct and cooperative transactivation of the ANF and cx40 promoters by Tbx5 and the homeodomain transcription factor Nkx2-5 was also demonstrated. These studies provide one potential explanation for
Holt-Oram syndrome
conduction system defects, suggest mechanisms for intrafamilial phenotypic variability, and account for related cardiac malformations caused by other transcription factor mutations.
...
PMID:A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. 1157 77
T-box genes encode transcription factors involved in morphogenesis and organogenesis of vertebrates and invertebrates. Mutations in human T-box genes TBX3,
TBX5
, and TBX1 cause severe genetic disorders known as Ulnar-Mammary syndrome (UMS),
Holt-Oram syndrome
(
HOS
), and DiGeorge syndrome, respectively. The crystal structure of the T-box domain of the first human T-box transcription factor, TBX3, in complex with DNA at 1.7 A resolution explains structural consequences of T-box domain point mutations observed in UMS and
HOS
patients. Comparison with the structure of the T-box domain from Xenopus laevis (Xbra) bound to DNA shows differences in several secondary structure elements and in the quaternary structure of the two complexes. TBX3 independently recognizes the two binding sites present in the palindromic DNA duplex, whereas in Xbra, binding to the palindrome is stabilized through interactions between the two monomers. The different quaternary structures suggest different DNA binding modes for T-box transcription factors.
...
PMID:Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome. 1200 33
Congenital heart disease is a significant cause of morbidity and mortality in humans, and gene mutations that underlie some of these anomalies are now being described. The NKX2.5 gene, which encodes a homeobox transcription factor, was initially discovered in mice through its similarity to the tinman gene of the fruitfly Drosophila. Tinman is required for formation of the dorsal pulsatile vessel or 'heart' of the fly. Tinman and NKX2.5 share structural and functional features, and in mice the gene is required for normal cardiac looping and differentiation of chamber myocardium. Humans with heterozygous mutations in the NKX2.5 gene generally have a disorder involving progressive atrio-ventricular conduction block and atrial septal defect, although sometimes other abnormalities including tetralogy of Fallot. The
TBX5
gene, which encodes another cardiac transcription factor that collaborates with NKX2.5, is also an important cardiac disease gene, with heterozygous mutations responsible for
Holt-Oram
(hand/heart) syndrome. These contributions to human pathology underscore the relevance of studying biological phenomena in lower organisms, and examination of other genes acting in this and associated pathways will expand our knowledge of congenital abnormalities and disease predisposition, and improve genetic counseling.
...
PMID:Developmental paradigms in heart disease: insights from tinman. 1217 84
We report on a Thai family with dominantly inherited malformation syndrome with upper limb anomalies, short stature, quadricuspid aortic valve, and minor craniofacial anomalies. The affected individuals comprised a mildly affected mother, a moderately affected daughter, and a most severely affected son. The daughter and son had short stature. The craniofacial abnormalities comprised frontal bossing, hypoplastic nasal bones, depressed nasal bridge, and broad nasal alae. The upper limb defects varies among the patients, ranging from radial ray defects in the mother through radial and ulnar ray defects with unilateral humeral hypoplasia in the daughter to radial ray defects with severe oligodactyly and bilateral humeral hypoplasia in the son. All patients in this family had hypoplasia of the shoulder girdle and resembled what is observed in many families with
Holt-Oram syndrome
. Moreover, the son showed quadricuspid aortic valve with mild aortic regurgitation. However, the present family did not show any mutation of the
TBX5
gene, a disease-causing gene of
Holt-Oram syndrome
. The present family deserves further investigation on other genes that play a role in the development of the upper limbs, particularly of radial rays.
...
PMID:A dominantly inherited malformation syndrome with short stature, upper limb anomaly, minor craniofacial anomalies, and absence of TBX5 mutations: report of a Thai family. 1221 Mar 27
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>